4//SEC Filing
Kaufman Jonathan H 4
Accession 0001753926-24-000573
CIK 0001347242other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 6:21 PM ET
Size
9.9 KB
Accession
0001753926-24-000573
Insider Transaction Report
Form 4
Kaufman Jonathan H
DirectorSee remarks below.10% Owner
Transactions
- Purchase
Common Stock
2024-03-19$0.87/sh+25,000$21,803→ 888,849 total - Award
Stock Options
2024-03-15+80,000→ 80,000 totalExercise: $0.77From: 2024-03-15Exp: 2034-03-15→ Common Stock (80,000 underlying) - Purchase
Common Stock
2024-03-18$0.79/sh+30,000$23,649→ 863,849 total
Footnotes (5)
- [F1]Open market purchase by the reporting person of 30,000 shares of common stock, par value $0.0001 per share (the "Common Stock").
- [F2]Reflects the weighted average price of the shares purchased on the open market in multiple transactions on March 18, 2024 at prices ranging from $0.77 to $0.80 per share, inclusive.
- [F3]The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.
- [F4]Open market purchase by the reporting person of 25,000 shares of Common Stock.
- [F5]Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on March 19, 2024 at prices ranging from $0.75 to $0.89 per share, inclusive.
Documents
Issuer
LIPELLA PHARMACEUTICALS INC.
CIK 0001347242
Entity typeother
Related Parties
1- filerCIK 0001959250
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 6:21 PM ET
- Size
- 9.9 KB